Certara Appoints John Reynders as New Independent Board Member
October 16, 2024 16:15 ET
|
Certara
Certara today announced the appointment of John Reynders, PhD to its Board of Directors, effective October 15, 2024.
Certara Completes Acquisition of Chemaxon
October 02, 2024 16:15 ET
|
Certara
Certara completes acquiring Chemaxon, a leading cheminformatics company that develops scientific informatics software used by the life sciences industry.
Certara & Ichnos Glenmark Innovation Collaboration Optimizes Dosing Strategy for Potential First-In-Class Cancer Drug
September 18, 2024 08:00 ET
|
Certara
Certara shared the results from its collaboration with Ichnos Glenmark Innovation (IGI) on the first-in-human dose prediction and selection for ISB 2001.
Certara Launches Phoenix™ Version 8.5 Drug Development Software
August 15, 2024 16:15 ET
|
Certara
Certara today announced the launch of Phoenix™ version 8.5 software, the pharmaceutical industry's gold standard in PK/PD modeling and simulation.
Certara Appoints New Chief Human Resources Officer & General Counsel
May 21, 2024 08:00 ET
|
Certara
Certara has appointed Rona Anhalt as Chief Human Resources Officer and Daniel Corcoran as General Counsel.
Certara Launches Cloud Platform to Further Unify its End-to-End Scientific Software Platform
April 16, 2024 08:00 ET
|
Certara
Certara Cloud is a unifying platform that integrates Certara's scientific software. Clients use a single ID to access and manage their licensed software.
Global Biosimulation Market to Surge, Predicted CAGR of 16.98% from 2024 to 2034, Driven by Pharmaceutical R&D and Technological Advancements
January 29, 2024 10:53 ET
|
Research and Markets
Dublin, Jan. 29, 2024 (GLOBE NEWSWIRE) -- The "Global Biosimulation Market" report has been added to ResearchAndMarkets.com's offering. The advent of cutting-edge biosimulation technologies is...
Certara Acquires Applied BioMath Expanding Its Biosimulation Portfolio to Industrialize New Capabilities for Optimal Dosing for Novel Therapies
December 13, 2023 16:30 ET
|
Certara
Combined Certara-Applied Biomath organization establishes the life sciences industry’s largest quantitative systems pharmacology center.
Biosimulation Market To Reach USD 12.7 Billion By 2032 Report By DataHorizzon Research
December 06, 2023 06:40 ET
|
DataHorizzon Research
Fort Collins, Colorado, Dec. 06, 2023 (GLOBE NEWSWIRE) -- According to DataHorizzon Research, The Biosimulation Market size was valued at USD 2.8 Billion in 2022 and is anticipated to reach USD 12.7...
Certara introduces Simcyp™ Biopharmaceutics software to increase efficiency of novel and generic drug formulation & development
November 21, 2023 16:30 ET
|
Certara
Certara's Simcyp™ Biopharmaceutics software helps biopharmaceutic, formulation & CMC scientists formulate complex new and generic drugs faster and cheaper.